A case report on the effective and safe use of ravulizumab in atypical hemolytic uremic syndrome during pregnancy

Abstract Background Atypical hemolytic uremic Syndrome (aHUS), a form of thrombotic microangiopathy (TMA), had a poor prognosis until the development of complement C5-inhibiting monoclonal antibodies, eculizumab and ravulizumab. While ravulizumab has shown effectiveness in treating postpartum TMA, d...

Cijeli opis

Bibliografski detalji

Glavni autori:	Abdulaziz Alkhaldi, Mamoun Elawad, Sultan Al Dalbhi, Bandar Alquraini, Alanoud Alshannan
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2026-04-01
Serija:	BMC Nephrology
Teme:	Atypical hemolytic uremic syndrome Case report Eculizumab Pregnancy Ravulizumab
Online pristup:	https://doi.org/10.1186/s12882-026-04950-w
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!